rivastigmine has been researched along with Dysphagia in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bu, K; Cheng, F; Han, W; Morris, R; Patel, D; Umeukeje, G; Zhu, T | 1 |
| Dautzenberg, PL; Nijboer, H | 1 |
| Aikawa, T; Arai, H; Ebihara, T; Furukawa, K; Kosaka, Y; Ohrui, T; Okinaga, S; Suzuki, M; Tomita, N; Une, K; Uwano, C | 1 |
4 other study(ies) available for rivastigmine and Dysphagia
| Article | Year |
|---|---|
Dysphagia Risk in Patients Prescribed Rivastigmine: A Systematic Analysis of FDA Adverse Event Reporting System.
Topics: Acetylcholinesterase; Alzheimer Disease; Butyrylcholinesterase; Cholinesterase Inhibitors; Clozapine; Deglutition Disorders; Donepezil; Galantamine; Humans; Memantine; Penicillamine; Risk Management; Rivastigmine; United States; United States Food and Drug Administration | 2022 |
Drug-induced sialorrhoea and excessive saliva accumulation.
Topics: Antipsychotic Agents; Benzodiazepines; Cholinesterase Inhibitors; Clozapine; Deglutition Disorders; Donepezil; Galantamine; Humans; Hypnotics and Sedatives; Indans; Phenylcarbamates; Pilocarpine; Piperidines; Quality of Life; Risperidone; Rivastigmine; Sialorrhea | 2009 |
[Progressive supranucleair palsy: acetylcholineeserase-inhibitor a possible therapy?].
Topics: Aged; Cholinesterase Inhibitors; Cognition Disorders; Deglutition Disorders; Diagnosis, Differential; Fatal Outcome; Female; Humans; Male; Middle Aged; Phenylcarbamates; Rivastigmine; Supranuclear Palsy, Progressive; Treatment Outcome | 2009 |
Rivastigmine dermal patch solves eating problems in an individual with advanced Alzheimer's disease.
Topics: Aged, 80 and over; Alzheimer Disease; Cholinesterase Inhibitors; Deglutition Disorders; Female; Humans; Phenylcarbamates; Rivastigmine; Severity of Illness Index; Transdermal Patch | 2012 |